Thybaud Veronique, Lorge Elisabeth, Levy Dan D, van Benthem Jan, Douglas George R, Marchetti Francesco, Moore Martha M, Schoeny Rita
Sanofi, Global Preclinical Safety, Vitry-sur-Seine, France.
Servier Group, Gidy, France.
Environ Mol Mutagen. 2017 Jun;58(5):284-295. doi: 10.1002/em.22079. Epub 2017 Mar 7.
The Organization for Economic Cooperation and Development (OECD) recently revised the test guidelines (TGs) for genetic toxicology. This article describes the main issues addressed during the revision process, and the new and consistent recommendations made in the revised TGs for: (1) demonstration of laboratory proficiency; (2) generation and use of robust historical control data; (3) improvement of the statistical power of the tests; (4) selection of top concentration for in vitro assays; (5) consistent data interpretation and determination of whether the result is clearly positive, clearly negative or needs closer consideration; and, (6) consideration of 3R's for in vivo assay design. The revision process resulted in improved consistency among OECD TGs (including the newly developed ones) and more comprehensive recommendations for the conduct and the interpretation of the assays. Altogether, the recommendations made during the revision process should improve the efficiency, by which the data are generated, and the quality and reliability of test results. Environ. Mol. Mutagen. 58:284-295, 2017. © 2017 Wiley Periodicals, Inc.
经济合作与发展组织(OECD)最近修订了遗传毒理学测试指南(TGs)。本文描述了修订过程中涉及的主要问题,以及修订后的测试指南针对以下方面提出的新的一致建议:(1)实验室能力验证;(2)稳健的历史对照数据的生成与使用;(3)提高测试的统计效力;(4)体外试验最高浓度的选择;(5)一致的数据解释以及确定结果是明确阳性、明确阴性还是需要进一步考虑;以及(6)体内试验设计的3R原则考量。修订过程提高了经合组织测试指南(包括新制定的指南)之间的一致性,并为试验的开展和解释提供了更全面的建议。总体而言,修订过程中提出的建议应能提高数据生成的效率以及测试结果的质量和可靠性。《环境与分子诱变》58:284 - 295, 2017。© 2017威利期刊公司